Financials

  • Market Capitalization 122.68 M
  • Employee 5
  • Founded 2005
  • CEO N/A
  • Website www.neonc.com
  • Headquarter Delaware, United States
  • FIGI BBG01KPDB522
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.18
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3817
VTVT
vTv Therapeutics Inc. - Class A Common Stock
31.95 USD-0.16%-7.10%-1.14%+55.85%126.33 M USD
3827
ENGN
enGene Therapeutics Inc. - Common Stock
1.86 USD+1.09%-2.11%+3.91%-77.86%124.60 M USD
3831
VANI
Vivani Medical, Inc. - Common Stock
1.36 USD-2.16%-4.90%-0.73%+19.30%122.68 M USD
3844
RANI
Rani Therapeutics Holdings, Inc. - Class A Common Stock
0.86 USD+1.18%-2.27%+10.26%+75.51%119.88 M USD